These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2994 related articles for article (PubMed ID: 33734299)

  • 21. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
    Sholzberg M; Tang GH; Rahhal H; AlHamzah M; Kreuziger LB; Áinle FN; Alomran F; Alayed K; Alsheef M; AlSumait F; Pompilio CE; Sperlich C; Tangri S; Tang T; Jaksa P; Suryanarayan D; Almarshoodi M; Castellucci LA; James PD; Lillicrap D; Carrier M; Beckett A; Colovos C; Jayakar J; Arsenault MP; Wu C; Doyon K; Andreou ER; Dounaevskaia V; Tseng EK; Lim G; Fralick M; Middeldorp S; Lee AYY; Zuo F; da Costa BR; Thorpe KE; Negri EM; Cushman M; Jüni P;
    BMJ; 2021 Oct; 375():n2400. PubMed ID: 34649864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.
    Parzy G; Daviet F; Puech B; Sylvestre A; Guervilly C; Porto A; Hraiech S; Chaumoitre K; Papazian L; Forel JM
    Crit Care Med; 2020 Oct; 48(10):e971-e975. PubMed ID: 32618700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial.
    Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Anderson JL; Li J; Rodriguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple B; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
    JAMA; 2019 Sep; 322(9):834-842. PubMed ID: 31479138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit: The Oxygen-ICU Randomized Clinical Trial.
    Girardis M; Busani S; Damiani E; Donati A; Rinaldi L; Marudi A; Morelli A; Antonelli M; Singer M
    JAMA; 2016 Oct; 316(15):1583-1589. PubMed ID: 27706466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
    Lopes RD; de Barros E Silva PGM; Furtado RHM; Macedo AVS; Bronhara B; Damiani LP; Barbosa LM; de Aveiro Morata J; Ramacciotti E; de Aquino Martins P; de Oliveira AL; Nunes VS; Ritt LEF; Rocha AT; Tramujas L; Santos SV; Diaz DRA; Viana LS; Melro LMG; de Alcântara Chaud MS; Figueiredo EL; Neuenschwander FC; Dracoulakis MDA; Lima RGSD; de Souza Dantas VC; Fernandes ACS; Gebara OCE; Hernandes ME; Queiroz DAR; Veiga VC; Canesin MF; de Faria LM; Feitosa-Filho GS; Gazzana MB; Liporace IL; de Oliveira Twardowsky A; Maia LN; Machado FR; de Matos Soeiro A; Conceição-Souza GE; Armaganijan L; Guimarães PO; Rosa RG; Azevedo LCP; Alexander JH; Avezum A; Cavalcanti AB; Berwanger O;
    Lancet; 2021 Jun; 397(10291):2253-2263. PubMed ID: 34097856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombosis and Bleeding After Implementation of an Intermediate-Dose Prophylactic Anticoagulation Protocol in ICU Patients With COVID-19: A Multicenter Screening Study.
    Al-Abani K; Kilhamn N; Maret E; Mårtensson J
    J Intensive Care Med; 2022 Apr; 37(4):480-490. PubMed ID: 34821162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study.
    Rentsch CT; Beckman JA; Tomlinson L; Gellad WF; Alcorn C; Kidwai-Khan F; Skanderson M; Brittain E; King JT; Ho YL; Eden S; Kundu S; Lann MF; Greevy RA; Ho PM; Heidenreich PA; Jacobson DA; Douglas IJ; Tate JP; Evans SJW; Atkins D; Justice AC; Freiberg MS
    BMJ; 2021 Feb; 372():n311. PubMed ID: 33574135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.
    Piazza G; Spyropoulos AC; Hsia J; Goldin M; Towner WJ; Go AS; Bull TM; Weng S; Lipardi C; Barnathan ES; Bonaca MP;
    Circulation; 2023 Jun; 147(25):1891-1901. PubMed ID: 37154020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
    Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
    Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
    ; ; ; Goligher EC; Bradbury CA; McVerry BJ; Lawler PR; Berger JS; Gong MN; Carrier M; Reynolds HR; Kumar A; Turgeon AF; Kornblith LZ; Kahn SR; Marshall JC; Kim KS; Houston BL; Derde LPG; Cushman M; Tritschler T; Angus DC; Godoy LC; McQuilten Z; Kirwan BA; Farkouh ME; Brooks MM; Lewis RJ; Berry LR; Lorenzi E; Gordon AC; Ahuja T; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Contreras A; Costantini TW; de Brouwer S; Detry MA; Duggal A; Džavík V; Effron MB; Eng HF; Escobedo J; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Froess JD; Fu Z; Galanaud JP; Galen BT; Gandotra S; Girard TD; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Haniffa R; Hegde SM; Hendrickson CM; Higgins AM; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Huang DT; Hudock K; Hunt BJ; Husain M; Hyzy RC; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski A; King AJ; Knudson MM; Kornblith AE; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Gallego Lima F; Linstrum K; Litton E; Lopez-Sendon J; Lother SA; Marten N; Saud Marinez A; Martinez M; Mateos Garcia E; Mavromichalis S; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nicolau JC; Nunez-Garcia B; Park JJ; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pompilio M; Quigley JG; Rosenson RS; Rost NS; Rowan K; Santos FO; Santos M; Santos MO; Satterwhite L; Saunders CT; Schreiber J; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Singhal AB; Slutsky AS; Solvason D; Stanworth SJ; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Widmer RJ; Wilson JG; Yuriditsky E; Zhong Y; Berry SM; McArthur CJ; Neal MD; Hochman JS; Webb SA; Zarychanski R
    N Engl J Med; 2021 Aug; 385(9):777-789. PubMed ID: 34351722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.
    Merli G; Spiro TE; Olsson CG; Abildgaard U; Davidson BL; Eldor A; Elias D; Grigg A; Musset D; Rodgers GM; Trowbridge AA; Yusen RD; Zawilska K;
    Ann Intern Med; 2001 Feb; 134(3):191-202. PubMed ID: 11177331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID).
    Lemos ACB; do Espírito Santo DA; Salvetti MC; Gilio RN; Agra LB; Pazin-Filho A; Miranda CH
    Thromb Res; 2020 Dec; 196():359-366. PubMed ID: 32977137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
    JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study.
    Aljuhani O; Al Sulaiman K; Hafiz A; Eljaaly K; Alharbi A; Algarni R; Al Homaid S; Kahtani K; Alsulaiman T; Vishwakarma R; Al Ghamdi G; Alalawi M; Korayem GB
    Saudi Pharm J; 2022 Apr; 30(4):398-406. PubMed ID: 35136364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Coronavirus Infection (COVID-19) Related Thrombotic and Bleeding Complications in Critically Ill Patients: Experience from an Academic Medical Center.
    Jayakrishnan T; Haag A; Mealy S; Minich C; Attah A; Turk M; Alrifai N; Alhuneafat L; Khoury F; Nasrullah A; Wedgeworth P; Mosley M; Vashistha K; Bakalov V; Chaturvedi A; Sangli S
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.
    Goldhaber SZ; Leizorovicz A; Kakkar AK; Haas SK; Merli G; Knabb RM; Weitz JI;
    N Engl J Med; 2011 Dec; 365(23):2167-77. PubMed ID: 22077144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major bleeding complications in critically ill patients with COVID-19 pneumonia.
    Godier A; Clausse D; Meslin S; Bazine M; Lang E; Huche F; Cholley B; Hamada SR
    J Thromb Thrombolysis; 2021 Jul; 52(1):18-21. PubMed ID: 33646501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial.
    Bouadma L; Mekontso-Dessap A; Burdet C; Merdji H; Poissy J; Dupuis C; Guitton C; Schwebel C; Cohen Y; Bruel C; Marzouk M; Geri G; Cerf C; Mégarbane B; Garçon P; Kipnis E; Visseaux B; Beldjoudi N; Chevret S; Timsit JF;
    JAMA Intern Med; 2022 Sep; 182(9):906-916. PubMed ID: 35788622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of the safety and efficacy of enoxaparin in patients with COVID-19.
    Albisinni R; Vitrone M; Ursi MP; Spiezia S; Salemme A; Florio LL; Boccia F; Iossa D; Zampino R; Atripaldi L; Squillante F; Maturo N; Fraganza F; Severino S; Punzi R; Fiorentino G
    Blood Transfus; 2022 Nov; 20(6):495-504. PubMed ID: 36469432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
    Büller HR; Davidson BL; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob G; Segers AE; Cariou R; Leeuwenkamp O; Lensing AW;
    Ann Intern Med; 2004 Jun; 140(11):867-73. PubMed ID: 15172900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 150.